We focus on fighting COVID-endemic illnesses and cancers.
THE PANDEMIC BROKE OUR IMMUNITY
It is now undeniable – COVID19 broke our immunity with grim consequences.
Our Approach
From its inception, Xylonix has focused on the immunity issues of dysfunctional macrophages. These reprogrammed macrophages enable cancers to be immune evasive, highly metastatic, and treatment resistant (read). This focus led to the development of our oncology agent C010DS-Zn (read). Early in the COVID pandemic our understanding of dysfunctional macrophages enabled us to quickly identify the close resemblance between COVID-reprogrammed macrophages (read) and cancer-associated macrophages (read), and the associated long-term health effects of COVID19, such as myocarditis, diabetes, and MIS-C (read). Since then, we have been preparing the scientific and product framework for the prevention of COVID19 and treatment of its long-term health effects (read, read).
Our development DNA:
Useful. Scientific. Accessible.
Reduce the infection frequency of COVID19 and other viral infectious diseases.
Risks of deaths and hospitalizations from all cause exponentially increase after repeat infections from COVID19 (read). We developed a PVD-Iodine-based antiseptic nasal spray suitable for frequent disinfection, to help curb the re-infection risks from a broad range of pathogens, like COVID19, and to help promote the idea of nasal hygiene. It is also useful for Rhinitis - nasal allergy demands. Available now.
Reduce baseline systemic inflammation.
Chronic systemic exposure to inflammatory antigens contribute to systemic inflammation and aggravation leading toward autoimmune disease pathologies through endotoxemia. We developed a product for efficient removal of fecal endotoxin sources, which is a major source of inflammatory antigens in many autoimmune diseases (read). The products are also intrinsically useful for digestive health market demands. Now available, worldwide.
Restore the broken macrophage immunity to fight the supercharged cancer and long COVID.
With COVID19 becoming an endemic disease, the immune dysfunctions that drive the turbocharged cancers and long COVIDs can happen to anyone after repeat infections. While the virus cannot be stopped, we are working with collaborators at Duke-NUS to stop the cancers and long COVID by restoring the macrophage immunity that was broken by the reprogramming abilities of cancer and long COVID in the first place (read).
Prevent reinfections | Mitigate the risks
OUR PRODUCTS
Our Donations & Events
For Safer & Healthier Tomorrow
Winter travel season is fast approaching. Xylonix is helping our community stay safer by donating our Hygiene Nasal Spray to national and large public events. More recent event being our National Day Dinner @ Marine Parade CC supported with 1,000 units of the nasal sprays.
Big thank you to Pastor Samuel for helping us donate 300 Hygiene Nasal Spray to Faith City Church. Lets keep our community safe in this winter travel season. /FCCCSJ
Vestibulum morbi blandit cursus risus. Augue neque gravida in fermentum et sollicitudin ac orci phasellus. Massa massa ultricies mi quis hendrerit Vestibulum morbi blandit cursus risus. Augue neque gravida.
Simon Amour
TECHNICAL DIRECTORVestibulum morbi blandit cursus risus. Augue neque gravida in fermentum et sollicitudin ac orci phasellus. Massa massa ultricies mi quis hendrerit Vestibulum morbi blandit cursus risus. Augue neque gravida.
Robbie Lee
FOUNDER DIRECTORVestibulum morbi blandit cursus risus. Augue neque gravida in fermentum et sollicitudin ac orci phasellus. Massa massa ultricies mi quis hendrerit Vestibulum morbi blandit cursus risus. Augue neque gravida.
Emma Aria
SENIOR TECHNICIANMEDIA RELEASES
Vestibulum morbi blandit cursus risus. Augue neque gravida in fermentum et sollicitudin ac orci phasellus. Massa massa ultricies mi quis hendrerit.
